Genetic analysis of the gene coding for DARPP-32 (PPP1R1B) in Japanese patients with schizophrenia or bipolar disorder

Schizophrenia Research

Volumn 100, Issue 1-3, 2008, Pages 334-341

  Yoshimi, Akira ^a   Takahashi, Nagahide ^b   Saito, Shinichi ^b   Ito, Yoshihito ^b   Aleksic, Branko ^b   Usui, Hinako ^b   Kawamura, Yukiko ^a   Waki, Yukari ^a   Yoshikawa, Takeo ^c   Kato, Tadafumi ^c   Iwata, Nakao ^d   Inada, Toshiya ^e   Noda, Yukihiro ^a   Ozaki, Norio ^b  

^a MEIJO UNIVERSITY   (Japan)

^b NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^c RIKEN BRAIN SCIENCE INSTITUTE   (Japan)

^d FUJITA HEALTH UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^e TEIKYO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

32 kDa; Bipolar disorder; Dopamine and cAMP regulated phosphoprotein; Japanese population; Schizophrenia

Indexed keywords

PHOSPHOPROTEIN DARPP 32;

ADULT; ARTICLE; BIPOLAR DISORDER; CHROMOSOME 17Q; CHROMOSOME ABERRATION; CONTROLLED STUDY; FEMALE; GENE LINKAGE DISEQUILIBRIUM; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENOTYPE; HAPLOTYPE; HUMAN; JAPANESE; MAJOR CLINICAL STUDY; MALE; MENTAL PATIENT; PRIORITY JOURNAL; SCHIZOPHRENIA; SINGLE NUCLEOTIDE POLYMORPHISM;

ASIAN CONTINENTAL ANCESTRY GROUP; BIPOLAR DISORDER; CASE-CONTROL STUDIES; CHROMOSOME MAPPING; DNA MUTATIONAL ANALYSIS; DOPAMINE; DOPAMINE AND CAMP-REGULATED PHOSPHOPROTEIN 32; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HAPLOTYPES; HUMANS; JAPAN; LINKAGE DISEQUILIBRIUM; MALE; MIDDLE AGED; PEDIGREE; POLYMORPHISM, SINGLE NUCLEOTIDE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SCHIZOPHRENIA; SIGNAL TRANSDUCTION; VARIATION (GENETICS);

EID: 39849093601     PISSN: 09209964     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.schres.2007.10.028     Document Type: Article

References (25)

1. Albert K.A., Hemmings Jr. H.C., Adamo A.I., Potkin S.G., Akbarian S., Sandman C.A., Cotman C.W., Bunney Jr. W.E., and Greengard P. Evidence for decreased DARPP-32 in the prefrontal cortex of patients with schizophrenia. Arch. Gen. Psychiatry 59 8 (2002) 705-712
2. Balding D.J. A tutorial on statistical methods for population association studies. Nature reviews 7 10 (2006) 781-791
3. Beneyto M., Kristiansen L.V., Oni-Orisan A., McCullumsmith R.E., and Meador-Woodruff J.H. Abnormal glutamate receptor expression in the medial temporal lobe in schizophrenia and mood disorders. Neuropsychopharmacology (2007)
4. Cardno A.G., Holmans P.A., Rees M.I., Jones L.A., McCarthy G.M., Hamshere M.L., Williams N.M., Norton N., Williams H.J., Fenton I., Murphy K.C., Sanders R.D., Gray M.Y., O'Donovan M.C., McGuffin P., and Owen M.J. A genomewide linkage study of age at onset in schizophrenia. Am. J. Med. Genet. 105 5 (2001) 439-445
5. Catapano L.A., and Manji H.K. G protein-coupled receptors in major psychiatric disorders. Biochim. Biophys. Acta. 1768 4 (2007) 976-993
6. Chakravarti A. Population genetics-making sense out of sequence. Nat. Genet. 21 1 Suppl (1999) 56-60
7. de Bakker P.I., Yelensky R., Pe'er I., Gabriel S.B., Daly M.J., and Altshuler D. Efficiency and power in genetic association studies. Nat. Genet. 37 11 (2005) 1217-1223
8. Dick D.M., Foroud T., Flury L., Bowman E.S., Miller M.J., Rau N.L., Moe P.R., Samavedy N., El-Mallakh R., Manji H., Glitz D.A., Meyer E.T., Smiley C., Hahn R., Widmark C., McKinney R., Sutton L., Ballas C., Grice D., Berrettini W., Byerley W., Coryell W., DePaulo R., MacKinnon D.F., Gershon E.S., Kelsoe J.R., McMahon F.J., McInnis M., Murphy D.L., Reich T., Scheftner W., and Nurnberger Jr. J.I. Genomewide linkage analyses of bipolar disorder: a new sample of 250 pedigrees from the National Institute of Mental Health Genetics Initiative. Am. J. Hum. Genet. 73 1 (2003) 107-114
9. Dudbridge F. Pedigree disequilibrium tests for multilocus haplotypes. Genet. Epidemiol. 25 2 (2003) 115-121
10. Fienberg A.A., Hiroi N., Mermelstein P.G., Song W., Snyder G.L., Nishi A., Cheramy A., O'Callaghan J.P., Miller D.B., Cole D.G., Corbett R., Haile C.N., Cooper D.C., Onn S.P., Grace A.A., Ouimet C.C., White F.J., Hyman S.E., Surmeier D.J., Girault J., Nestler E.J., and Greengard P. DARPP-32: regulator of the efficacy of dopaminergic neurotransmission. Science 281 5378 (1998) 838-842
11. Ikeda M., Iwata N., Suzuki T., Kitajima T., Yamanouchi Y., Kinoshita Y., Inada T., and Ozaki N. No association of haplotype-tagging SNPs in TRAR4 with schizophrenia in Japanese patients. Schizophr. Res. 78 2-3 (2005) 127-130
12. Lee J.A., and Lupski J.R. Genomic rearrangements and gene copy-number alterations as a cause of nervous system disorders. Neuron 52 1 (2006) 103-121
13. Li C.H., Liao H.M., Hung T.W., and Chen C.H. Mutation analysis of DARPP-32 as a candidate gene for schizophrenia. Schizophr. Res. 87 1-3 (2006) 1-5
14. Meyer-Lindenberg A., Straub R.E., Lipska B.K., Verchinski B.A., Goldberg T., Callicott J.H., Egan M.F., Huffaker S.S., Mattay V.S., Kolachana B., Kleinman J.E., and Weinberger D.R. Genetic evidence implicating DARPP-32 in human frontostriatal structure, function, and cognition. J. Clin. Invest. 117 3 (2007) 672-682
15. Murray R.M., Sham P., Van Os J., Zanelli J., Cannon M., and McDonald C. A developmental model for similarities and dissimilarities between schizophrenia and bipolar disorder. Schizophr. Res. 71 2-3 (2004) 405-416
16. Nishi A., Watanabe Y., Higashi H., Tanaka M., Nairn A.C., and Greengard P. Glutamate regulation of DARPP-32 phosphorylation in neostriatal neurons involves activation of multiple signaling cascades. Proc. Natl. Acad. Sci. U.S.A. 102 4 (2005) 1199-1204
17. Purcell S., Cherny S.S., and Sham P.C. Genetic power calculator: design of linkage and association genetic mapping studies of complex traits. Bioinformatics 19 1 (2003) 149-150
18. Redon R., Ishikawa S., Fitch K.R., Feuk L., Perry G.H., Andrews T.D., Fiegler H., Shapero M.H., Carson A.R., Chen W., Cho E.K., Dallaire S., Freeman J.L., Gonzalez J.R., Gratacos M., Huang J., Kalaitzopoulos D., Komura D., MacDonald J.R., Marshall C.R., Mei R., Montgomery L., Nishimura K., Okamura K., Shen F., Somerville M.J., Tchinda J., Valsesia A., Woodwark C., Yang F., Zhang J., Zerjal T., Armengol L., Conrad D.F., Estivill X., Tyler-Smith C., Carter N.P., Aburatani H., Lee C., Jones K.W., Scherer S.W., and Hurles M.E. Global variation in copy number in the human genome. Nature 444 7118 (2006) 444-454
19. Schwab S.G., Hoefgen B., Hanses C., Hassenbach M.B., Albus M., Lerer B., Trixler M., Maier W., and Wildenauer D.B. Further evidence for association of variants in the AKT1 gene with schizophrenia in a sample of European sib-pair families. Biol. Psychiatry 58 6 (2005) 446-450
20. Schwab S.G., Knapp M., Mondabon S., Hallmayer J., Borrmann-Hassenbach M., Albus M., Lerer B., Rietschel M., Trixler M., Maier W., and Wildenauer D.B. Support for association of schizophrenia with genetic variation in the 6p22.3 gene, dysbindin, in sib-pair families with linkage and in an additional sample of triad families. Am. J. Hum. Genet. 72 1 (2003) 185-190
21. Sharp A.J., Hansen S., Selzer R.R., Cheng Z., Regan R., Hurst J.A., Stewart H., Price S.M., Blair E., Hennekam R.C., Fitzpatrick C.A., Segraves R., Richmond T.A., Guiver C., Albertson D.G., Pinkel D., Eis P.S., Schwartz S., Knight S.J., and Eichler E.E. Discovery of previously unidentified genomic disorders from the duplication architecture of the human genome. Nat. Genet. 38 9 (2006) 1038-1042
22. Shifman S., Bronstein M., Sternfeld M., Pisante-Shalom A., Lev-Lehman E., Weizman A., Reznik I., Spivak B., Grisaru N., Karp L., Schiffer R., Kotler M., Strous R.D., Swartz-Vanetik M., Knobler H.Y., Shinar E., Beckmann J.S., Yakir B., Risch N., Zak N.B., and Darvasi A. A highly significant association between a COMT haplotype and schizophrenia. Am. J. Hum. Genet. 71 6 (2002) 1296-1302
23. Svenningsson P., Tzavara E.T., Carruthers R., Rachleff I., Wattler S., Nehls M., McKinzie D.L., Fienberg A.A., Nomikos G.G., and Greengard P. Diverse psychotomimetics act through a common signaling pathway. Science 302 5649 (2003) 1412-1415
24. Svenningsson P., Tzavara E.T., Witkin J.M., Fienberg A.A., Nomikos G.G., and Greengard P. Involvement of striatal and extrastriatal DARPP-32 in biochemical and behavioral effects of fluoxetine (Prozac). Proc. Natl. Acad. Sci. U. S. A. 99 5 (2002) 3182-3187
25. Wilson G.M., Flibotte S., Chopra V., Melnyk B.L., Honer W.G., and Holt R.A. DNA copy-number analysis in bipolar disorder and schizophrenia reveals aberrations in genes involved in glutamate signaling. Hum. Mol. Genet. 15 5 (2006) 743-749